The Science Behind Vioni+ — VyVa
Vioni+ Cellular Glow — The Science

The research behind Ioniplex®

A patented fulvic ionic mineral complex with 65+ trace minerals. Two issued US patents. One independent clinical study on nail condition. Multiple in vitro investigations on collagen pathways and mitochondrial metabolism.

How to read this page. Most Ioniplex® research consists of manufacturer-conducted laboratory studies (Sunny Biodiscovery, Santa Paula, California) and case studies — not independent peer-reviewed human randomized trials. We label every source by tier so you know what you're looking at. We never present manufacturer data as "clinical trial" data.

Independent Clinical Study

Tier B2 — Manufacturer-sponsored clinical evaluation Randomized, double-blind, placebo-controlled6 weeks

Boisits (2009) — Six-Week Evaluation of Oral Ioniplex on Nail Condition

Investigator: Edward K. Boisits, PhD. Study Coordinator: Rosemary McNicol, B.S., CCRC. Site: International Research Services, Inc., Port Chester, NY. Sponsor: Mineral BioSciences, LLC. Study No. 3411BK0609.

A randomized, double-blind, placebo-controlled clinical evaluation of two oral Ioniplex formulations on nail condition over 6 weeks.

Improvements in nail growth and nail condition parameters were measured against placebo. (Full clinical report on file with Mineral BioSciences.)

Why this matters: This is the closest thing in the Ioniplex research portfolio to an independent clinical evaluation — randomized, double-blind, placebo-controlled — even though it was sponsored by the manufacturer.

Manufacturer Laboratory Research — Mechanism & Bioavailability

Tier C — Manufacturer in vitroSunny Biodiscovery Report 697-BIOAV2015

Bioavailability of Ioniplex™ in Human Dermal Fibroblasts (in vitro)

Lab: Sunny Biodiscovery, Inc. (Santa Paula, CA). Prepared for Mineral BioSciences, March 23, 2015.

"Minerals complexed in Ioniplex™ chelating carbon complex may not be detected as 'free ionic'" — supporting the supplier's positioning that Ioniplex delivers minerals in a form designed for cellular uptake.

Why this matters: Vioni+'s premise is that mineral nutrition is about delivery, not dose. This in vitro report supports that mechanism story at the cellular level. It is not, however, a human bioavailability trial — and we're explicit about that.

Tier C — Manufacturer in vitroSunny Biodiscovery2006 / rev. 2014

Effect of Ioniplex™ on Mitochondrial Metabolism in Cell Culture

Lab: Sunny Biodiscovery, Inc. Comparative MTT assay (a standard measure of mitochondrial respiratory activity) on human dermal fibroblasts. Ioniplex™ compared against energy drinks (No Fear, Full Throttle).

Ioniplex™ increased succinate dehydrogenase activity (a key mitochondrial respiratory chain enzyme) in cell culture compared to controls.

Why this matters: The mechanistic basis for Ioniplex's "cellular energy" positioning. Cell-culture data, not human data — but consistent with the larger story.

Tier C — Manufacturer in vitroSunny Biodiscovery Report 400COL2010

Effect on Type I Collagen Levels in Human Dermal Fibroblasts (in vitro)

Lab: Sunny Biodiscovery, Inc. April 12, 2010. Prepared for Global Organics.

In vitro assay testing the effect of Ioniplex-containing test materials on Type I collagen secretion by aged dermal fibroblast cells.

Type I collagen secretion increased in cell models containing the Ioniplex test materials.

Why this matters: Collagen production is a key concern for skin appearance after 35. This cell-culture data describes one pathway by which the trace minerals in Ioniplex may support skin's natural processes. Cell-culture results don't always translate to humans — we're cautious about overclaiming.

Tier C — Manufacturer in vitroSunny Biodiscovery Report 466A2011

Commercial Formulations With vs Without Ioniplex on Muscle and Bone Cells

Lab: Sunny Biodiscovery, Inc. February 22, 2011. Prepared for Mineral BioSciences.

Compared Isagenix and Ensure (commercial supplement beverages) with and without added Ioniplex on human skeletal muscle (HSMC) and bone cell populations.

Adding Ioniplex to commercial formulations was associated with increased metabolic activity and protein production in muscle and bone cell models.

Why this matters: Supports the broader story that Ioniplex's trace mineral nutrition may be relevant beyond skin and nail health. Pre-clinical data only — but a useful frame for the "cellular nutrition" positioning.

Manufacturer Technical Dossier

Tier C — Manufacturer white paper2021

Ioniplex White Paper (October 2021)

Publisher: Mineral BioSciences. Comprehensive technical dossier covering Ioniplex's composition (65+ trace minerals in ionic form), production methods, applications, and supporting research bibliography.

How we use it: Background reference and footnote source. Specific claim percentages from this white paper should always be qualified as "manufacturer laboratory data on file" — never as "clinical research" or "proven."

Patents

US Patent 8,709,497Granted

Mineral, Cosmetic, Pharmaceutical, and Agriculture Compositions and Methods for Producing the Same

Mineral BioSciences®. Covers methods for producing mineral compositions including a large number of naturally occurring minerals that facilitate delivery into the body — for cosmetic, pharmaceutical, agricultural, and nutraceutical applications.

US Patent 8,927,031Granted

Anti-Glycation Methods and Compositions

Mineral BioSciences®. Covers compositions used to address glycation events in humans and animals.

US Patent PendingFiled 2016

Methods and Compositions for Modulating Muscle and Bone Loss

Mineral BioSciences®. Pending application. Methods to address age-related muscle degeneration in humans and animals.

Manufacturing & Quality Assurance

FDA Reg. No. 10063446198cGMP-compliant

Manufactured in an FDA-registered facility

Vioni+ is manufactured in an FDA-registered, cGMP-compliant facility.

ISO-accredited testingBatch WG-251206

Independent batch testing — FARE Labs Private Limited

Current production batch verified:

  • Ioniplex per gummy: 208.14 mg (label spec NLT 90% of declared)
  • Heavy metals (As, Pb, Hg, Cd): all below limit of quantification
  • Pathogens: all absent
  • Total aerobic count: <10 cfu/g (spec NMT 1,000)
  • Sugar: not detected
Required disclaimers. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Not intended for pregnant or breastfeeding women or children under 18. Manufactured in an FDA-registered, cGMP-compliant facility. Independently tested by an ISO-accredited laboratory. Ioniplex® is a registered trademark of Mineral BioSciences®, US Patents 8,709,497 and 8,927,031 + 1 patent pending.